#METABOLOMICS WORKBENCH STUDY_ID:ST000253 ANALYSIS_ID:AN000400
VERSION             	1
CREATED_ON          	2016-09-17
#PROJECT
PR:PROJECT_TITLE                 	Metabolomics of Neonatal Pulmonary Hypertension (in a Rat Model)
PR:PROJECT_TYPE                  	Treatment and feeding study
PR:PROJECT_SUMMARY               	This study aims to identify identify disrupted metabolic pathways and patterns
PR:PROJECT_SUMMARY               	lung developent in a rat model of bronchopulmonary dysplasia and growth
PR:PROJECT_SUMMARY               	Pregnant Sprague Dawley rats (gestational day 15) were housed in plsatic cages
PR:PROJECT_SUMMARY               	constant conditions. After 7-d acclimization period, litters were delivered and
PR:PROJECT_SUMMARY               	randomly distributed between litters of 10 pups (N, normal intake) or litters
PR:PROJECT_SUMMARY               	17 pups (R, restricted intake). Normal and restriced intake pups were exposed
PR:PROJECT_SUMMARY               	75% oxygen (O, oxygen) in a Plexiglass chamber or to 21% oxygen (A, room air)
PR:PROJECT_SUMMARY               	for 14 days, with daily rotation of dams to avoid oxygen toxicity. Both plasma
PR:PROJECT_SUMMARY               	lung tissue underwent metabolomics analysis.
PR:INSTITUTE                     	University of California, Davis
PR:DEPARTMENT                    	Department of Pediatrics, School of Medicine
PR:LABORATORY                    	Wedgwood lab
PR:LAST_NAME                     	Wedgwood
PR:FIRST_NAME                    	Stephen
PR:ADDRESS                       	1002B, Research II, 4625 2nd Ave., Sacramento, CA 95817
PR:EMAIL                         	stephen.wedwood@ucdmc.ucdavis.edu
PR:PHONE                         	+1-916-734-1518
PR:FUNDING_SOURCE                	National Institute of Health U24 DK092993
#STUDY
ST:STUDY_TITLE                   	NIH WCMC Pilot & Feasibility Project: Metabolomics of Neonatal Pulmonary
ST:STUDY_TYPE                    	Treatment and feeding study
ST:STUDY_SUMMARY                 	Targeted metabolomic analyses of oxylipins were performed on 16 rat plasma and
ST:STUDY_SUMMARY                 	samples collected from rats euthanized at 14 days following exposure to growth
ST:STUDY_SUMMARY                 	and/or hyperoxia. Samples were analyzed by UPLC-MS/MS using a Waters Acquity
ST:STUDY_SUMMARY                 	and detected on an API 4000 QTrap (AB Sciex, Framingham, MA, USA) by multiple
ST:STUDY_SUMMARY                 	monitoring (MRM) after negative mode electrospray ionization.
ST:INSTITUTE                     	University of California, Davis
ST:DEPARTMENT                    	U.S.D.A. Western Human Nutrition Research Center
ST:LABORATORY                    	Newman Lab
ST:LAST_NAME                     	Newman
ST:FIRST_NAME                    	John
ST:ADDRESS                       	430 W. Health Sciences Dr., Davis, CA 95616
ST:EMAIL                         	john.newman@ars.usda.gov
ST:PHONE                         	+1-530-752-1009
ST:NUM_GROUPS                    	4
ST:TOTAL_SUBJECTS                	16
#SUBJECT
SU:SUBJECT_TYPE                  	Animal
SU:SUBJECT_SPECIES               	Rattus norvegicus
SU:TAXONOMY_ID                   	10116
SU:AGE_OR_AGE_RANGE              	2 weeks
SU:ANIMAL_HOUSING                	Litters of 10 (N group) or 17 (R group)
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Additional sample data
SUBJECT_SAMPLE_FACTORS           	-	WEDG-1	Treatment:AN; Room Air, normal litter (no restricted nutritional intake) | Tissue:Lung	Oxylipin analysis=Wedg Lungs Oxys-WEDG-1.mzML; Osborn ID=AN1F3
SUBJECT_SAMPLE_FACTORS           	-	WEDG-10	Treatment:AN; Room Air, normal litter (no restricted nutritional intake) | Tissue:Lung	Oxylipin analysis=Wedg Lungs Oxys-WEDG-10.mzML; Osborn ID=AN3M3
SUBJECT_SAMPLE_FACTORS           	-	WEDG-20	Treatment:AN; Room Air, normal litter (no restricted nutritional intake) | Tissue:Lung	Oxylipin analysis=Wedg Lungs Oxys-WEDG-20.mzML; Osborn ID=AN2F3
SUBJECT_SAMPLE_FACTORS           	-	WEDG-7	Treatment:AN; Room Air, normal litter (no restricted nutritional intake) | Tissue:Lung	Oxylipin analysis=Wedg Lungs Oxys-WEDG-7.mzML; Osborn ID=AN4M3
SUBJECT_SAMPLE_FACTORS           	-	PAW-13	Treatment:AN; Room Air, normal litter (no restricted nutritional intake) | Tissue:Plasma	Oxylipin analysis=Osb_Tan_Raj_Oxys-PAW-13.mzML; Osborn ID=AN1F3
SUBJECT_SAMPLE_FACTORS           	-	PAW-16	Treatment:AN; Room Air, normal litter (no restricted nutritional intake) | Tissue:Plasma	Oxylipin analysis=Osb_Tan_Raj_Oxys-PAW-16.mzML; Osborn ID=AN4M3
SUBJECT_SAMPLE_FACTORS           	-	PAW-4	Treatment:AN; Room Air, normal litter (no restricted nutritional intake) | Tissue:Plasma	Oxylipin analysis=Osb_Tan_Raj_Oxys-PAW-4.mzML; Osborn ID=AN2F3
SUBJECT_SAMPLE_FACTORS           	-	PAW-8	Treatment:AN; Room Air, normal litter (no restricted nutritional intake) | Tissue:Plasma	Oxylipin analysis=Osb_Tan_Raj_Oxys-PAW-8.mzML; Osborn ID=AN3M3
SUBJECT_SAMPLE_FACTORS           	-	WEDG-15	Treatment:AR; Room Air, restricted intake | Tissue:Lung	Oxylipin analysis=Wedg Lungs Oxys-WEDG-15.mzML; Osborn ID=AR6M3
SUBJECT_SAMPLE_FACTORS           	-	WEDG-17	Treatment:AR; Room Air, restricted intake | Tissue:Lung	Oxylipin analysis=Wedg Lungs Oxys-WEDG-17.mzML; Osborn ID=AR7F3
SUBJECT_SAMPLE_FACTORS           	-	WEDG-19	Treatment:AR; Room Air, restricted intake | Tissue:Lung	Oxylipin analysis=Wedg Lungs Oxys-WEDG-19.mzML; Osborn ID=AR5M3
SUBJECT_SAMPLE_FACTORS           	-	WEDG-6	Treatment:AR; Room Air, restricted intake | Tissue:Lung	Oxylipin analysis=Wedg Lungs Oxys-WEDG-6.mzML; Osborn ID=AR1F3
SUBJECT_SAMPLE_FACTORS           	-	PAW-15	Treatment:AR; Room Air, restricted intake | Tissue:Plasma	Oxylipin analysis=Osb_Tan_Raj_Oxys-PAW-15.mzML; Osborn ID=AR7F3
SUBJECT_SAMPLE_FACTORS           	-	PAW-3	Treatment:AR; Room Air, restricted intake | Tissue:Plasma	Oxylipin analysis=Osb_Tan_Raj_Oxys-PAW-3.mzML; Osborn ID=AR5M3
SUBJECT_SAMPLE_FACTORS           	-	PAW-5	Treatment:AR; Room Air, restricted intake | Tissue:Plasma	Oxylipin analysis=Osb_Tan_Raj_Oxys-PAW-5.mzML; Osborn ID=AR6M3
SUBJECT_SAMPLE_FACTORS           	-	PAW-7	Treatment:AR; Room Air, restricted intake | Tissue:Plasma	Oxylipin analysis=Osb_Tan_Raj_Oxys-PAW-7.mzML; Osborn ID=AR1F3
SUBJECT_SAMPLE_FACTORS           	-	WEDG-14	Treatment:ON; 75% oxygen, normal litter | Tissue:Lung	Oxylipin analysis=Wedg Lungs Oxys-WEDG-14.mzML; Osborn ID=ON6M3
SUBJECT_SAMPLE_FACTORS           	-	WEDG-18	Treatment:ON; 75% oxygen, normal litter | Tissue:Lung	Oxylipin analysis=Wedg Lungs Oxys-WEDG-18.mzML; Osborn ID=ON4M3
SUBJECT_SAMPLE_FACTORS           	-	WEDG-2	Treatment:ON; 75% oxygen, normal litter | Tissue:Lung	Oxylipin analysis=Wedg Lungs Oxys-WEDG-2.mzML; Osborn ID=ON7F3
SUBJECT_SAMPLE_FACTORS           	-	WEDG-3	Treatment:ON; 75% oxygen, normal litter | Tissue:Lung	Oxylipin analysis=Wedg Lungs Oxys-WEDG-3.mzML; Osborn ID=ON8F3
SUBJECT_SAMPLE_FACTORS           	-	PAW-10	Treatment:ON; 75% oxygen, normal litter | Tissue:Plasma	Oxylipin analysis=Osb_Tan_Raj_Oxys-PAW-10.mzML; Osborn ID=ON4M3
SUBJECT_SAMPLE_FACTORS           	-	PAW-12	Treatment:ON; 75% oxygen, normal litter | Tissue:Plasma	Oxylipin analysis=Osb_Tan_Raj_Oxys-PAW-12.mzML; Osborn ID=ON7F3
SUBJECT_SAMPLE_FACTORS           	-	PAW-6	Treatment:ON; 75% oxygen, normal litter | Tissue:Plasma	Oxylipin analysis=Osb_Tan_Raj_Oxys-PAW-6.mzML; Osborn ID=ON8F3
SUBJECT_SAMPLE_FACTORS           	-	PAW-9	Treatment:ON; 75% oxygen, normal litter | Tissue:Plasma	Oxylipin analysis=Osb_Tan_Raj_Oxys-PAW-9.mzML; Osborn ID=ON6M3
SUBJECT_SAMPLE_FACTORS           	-	WEDG-11	Treatment:OR; 75% oxygen, restricted intake | Tissue:Lung	Oxylipin analysis=Wedg Lungs Oxys-WEDG-11.mzML; Osborn ID=OR9M3
SUBJECT_SAMPLE_FACTORS           	-	WEDG-13	Treatment:OR; 75% oxygen, restricted intake | Tissue:Lung	Oxylipin analysis=Wedg Lungs Oxys-WEDG-13.mzML; Osborn ID=OR6F3
SUBJECT_SAMPLE_FACTORS           	-	WEDG-5	Treatment:OR; 75% oxygen, restricted intake | Tissue:Lung	Oxylipin analysis=Wedg Lungs Oxys-WEDG-5.mzML; Osborn ID=OR5F3
SUBJECT_SAMPLE_FACTORS           	-	WEDG-9	Treatment:OR; 75% oxygen, restricted intake | Tissue:Lung	Oxylipin analysis=Wedg Lungs Oxys-WEDG-9.mzML; Osborn ID=OR4M3
SUBJECT_SAMPLE_FACTORS           	-	PAW-1	Treatment:OR; 75% oxygen, restricted intake | Tissue:Plasma	Oxylipin analysis=Osb_Tan_Raj_Oxys-PAW-1.mzML; Osborn ID=OR5F3
SUBJECT_SAMPLE_FACTORS           	-	PAW-11	Treatment:OR; 75% oxygen, restricted intake | Tissue:Plasma	Oxylipin analysis=Osb_Tan_Raj_Oxys-PAW-11.mzML; Osborn ID=OR9M3
SUBJECT_SAMPLE_FACTORS           	-	PAW-14	Treatment:OR; 75% oxygen, restricted intake | Tissue:Plasma	Oxylipin analysis=Osb_Tan_Raj_Oxys-PAW-14.mzML; Osborn ID=OR6F3
SUBJECT_SAMPLE_FACTORS           	-	PAW-2	Treatment:OR; 75% oxygen, restricted intake | Tissue:Plasma	Oxylipin analysis=Osb_Tan_Raj_Oxys-PAW-2.mzML; Osborn ID=OR4M3
#COLLECTION
CO:COLLECTION_SUMMARY            	-
CO:COLLECTION_PROTOCOL_FILENAME  	NewmanLab-F&BOxys-Protocol-PT.pdf
CO:SAMPLE_TYPE                   	Lung and plasma
CO:COLLECTION_METHOD             	Dissection
CO:STORAGE_CONDITIONS            	- 80°C
CO:STORAGE_VIALS                 	Eppendorf tubes
#TREATMENT
TR:TREATMENT_SUMMARY             	Litters of 10 pups (N, normal intake) or litters of 17 pups (R, restricted
TR:TREATMENT_SUMMARY             	Normal and restriced intake pups were exposed to 75% oxygen (O, oxygen) in a
TR:TREATMENT_SUMMARY             	chamber or to 21% oxygen (A, room air) continuously for 14 days,
TR:TREATMENT_PROTOCOL_FILENAME   	NewmanLab-F&BOxys-Protocol-PT.pdf
TR:TREATMENT                     	Intervention
TR:TREATMENT_DOSEDURATION        	1 week
TR:TREATMENT_VEHICLE             	Food availability, oxygen exposure
TR:ANIMAL_ENDP_EUTHANASIA        	2 weeks
TR:ANIMAL_ENDP_TISSUE_COLL_LIST  	Lung and plasma
TR:ANIMAL_ENDP_TISSUE_PROC_METHOD	Dissected, placed on dry ice
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	Tissues were pulverized on dry ice, enriched with deuterated surrogates,
SP:SAMPLEPREP_SUMMARY            	(BHT and EDTA), and the total lipid extract was isolated using 10:8:11
SP:SAMPLEPREP_SUMMARY            	acetate (v/v/v). Subsequently, esterified oxylipins were liberated via sodium
SP:SAMPLEPREP_SUMMARY            	Next, the remaining extract was eluted through a Waters Oasis-HLB cartridge.
SP:SAMPLEPREP_SUMMARY            	was added directly to a Waters Ostro plate, mixed with the surrogates,
SP:SAMPLEPREP_SUMMARY            	and acetonitrile and the extract eluted through. Both tissue and plasma
SP:SAMPLEPREP_SUMMARY            	were dried, reconstituted in 100?L 50:50 methanol:acetonitrile with internal
SP:SAMPLEPREP_SUMMARY            	1?phenyl?3?hexanoic acid urea and 1?cyclohexyl?3-dodecanoic acid urea
SP:SAMPLEPREP_SUMMARY            	St. Louis, MO) and filtered at 0.1 µm.
SP:SAMPLEPREP_PROTOCOL_FILENAME  	NewmanLab-F&BOxys-Protocol-PT.pdf
SP:EXTRACTION_METHOD             	Liquid:liquid with HLB solid phase extraction (Tissue); Ostro plate (Plasma)
SP:EXTRACT_CLEANUP               	HLB solid phase extraction (Tissue); Ostro plate (Plasma)
SP:EXTRACT_STORAGE               	- 20 °C
SP:SAMPLE_RESUSPENSION           	100 µL
SP:SAMPLE_SPIKING                	See sample prep protocol file
SP:ORGAN                         	Lung and plasma
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_SUMMARY        	Oxylipin analysis
CH:CHROMATOGRAPHY_TYPE           	-
CH:INSTRUMENT_NAME               	Waters Acquity
CH:COLUMN_NAME                   	-
CH:METHODS_FILENAME              	NewmanLab-F&BOxys-Protocol-PT.pdf
CH:COLUMN_TEMPERATURE            	60 C
CH:FLOW_GRADIENT                 	See protocol/methods file
CH:FLOW_RATE                     	0.25
CH:INTERNAL_STANDARD             	See protocol/methods file
CH:RETENTION_TIME                	See protocol/methods file
CH:SAMPLE_INJECTION              	5 L
CH:SOLVENT_A                     	0.1% acetic acid
CH:SOLVENT_B                     	90% ACN / 10% IPA
CH:ANALYTICAL_TIME               	16 min
CH:WEAK_WASH_SOLVENT_NAME        	20% methanol, 10% isopropanol
CH:WEAK_WASH_VOLUME              	600 L
CH:STRONG_WASH_SOLVENT_NAME      	50:50 Acetonitrile:Methanol
CH:STRONG_WASH_VOLUME            	600 L
CH:SAMPLE_LOOP_SIZE              	17 L
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
AN:LABORATORY_NAME               	Newman
AN:SOFTWARE_VERSION              	AB Sciex MultiQuant version 3.0.1
AN:OPERATOR_NAME                 	Michael La Frano
AN:DETECTOR_TYPE                 	API 4000 QTrap (AB Sciex, Framingham, MA, USA)
AN:DATA_FORMAT                   	.mzML
#MS
MS:INSTRUMENT_NAME               	Waters Acquity UPLC (Waters)
MS:INSTRUMENT_TYPE               	Oxylipins analysis
MS:MS_TYPE                       	QTRAP
MS:ION_MODE                      	ESI
MS:CAPILLARY_TEMPERATURE         	Plasma results
MS:CAPILLARY_VOLTAGE             	Negative
MS:MS_COMMENTS                   	Oxylipins analysis -Plasma results
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS	% Area Ratio
MS_METABOLITE_DATA_START
Samples	WEDG-1	WEDG-1	WEDG-10	WEDG-10	WEDG-20	WEDG-20	WEDG-7	WEDG-7	PAW-13	PAW-13	PAW-16	PAW-16	PAW-4	PAW-4	PAW-8	PAW-8	WEDG-15	WEDG-15	WEDG-17	WEDG-17	WEDG-19	WEDG-19	WEDG-6	WEDG-6	PAW-15	PAW-15	PAW-3	PAW-3	PAW-5	PAW-5	PAW-7	PAW-7	WEDG-14	WEDG-14	WEDG-18	WEDG-18	WEDG-2	WEDG-2	WEDG-3	WEDG-3	PAW-10	PAW-10	PAW-12	PAW-12	PAW-6	PAW-6	PAW-9	PAW-9	WEDG-11	WEDG-11	WEDG-13	WEDG-13	WEDG-5	WEDG-5	WEDG-9	WEDG-9	PAW-1	PAW-1	PAW-11	PAW-11	PAW-14	PAW-14	PAW-2	PAW-2
Factors	Treatment:AN; Room Air, normal litter (no restricted nutritional intake) | Tissue:Lung	Treatment:AN; Room Air, normal litter (no restricted nutritional intake) | Tissue:Lung	Treatment:AN; Room Air, normal litter (no restricted nutritional intake) | Tissue:Lung	Treatment:AN; Room Air, normal litter (no restricted nutritional intake) | Tissue:Lung	Treatment:AN; Room Air, normal litter (no restricted nutritional intake) | Tissue:Lung	Treatment:AN; Room Air, normal litter (no restricted nutritional intake) | Tissue:Lung	Treatment:AN; Room Air, normal litter (no restricted nutritional intake) | Tissue:Lung	Treatment:AN; Room Air, normal litter (no restricted nutritional intake) | Tissue:Lung	Treatment:AN; Room Air, normal litter (no restricted nutritional intake) | Tissue:Plasma	Treatment:AN; Room Air, normal litter (no restricted nutritional intake) | Tissue:Plasma	Treatment:AN; Room Air, normal litter (no restricted nutritional intake) | Tissue:Plasma	Treatment:AN; Room Air, normal litter (no restricted nutritional intake) | Tissue:Plasma	Treatment:AN; Room Air, normal litter (no restricted nutritional intake) | Tissue:Plasma	Treatment:AN; Room Air, normal litter (no restricted nutritional intake) | Tissue:Plasma	Treatment:AN; Room Air, normal litter (no restricted nutritional intake) | Tissue:Plasma	Treatment:AN; Room Air, normal litter (no restricted nutritional intake) | Tissue:Plasma	Treatment:AR; Room Air, restricted intake | Tissue:Lung	Treatment:AR; Room Air, restricted intake | Tissue:Lung	Treatment:AR; Room Air, restricted intake | Tissue:Lung	Treatment:AR; Room Air, restricted intake | Tissue:Lung	Treatment:AR; Room Air, restricted intake | Tissue:Lung	Treatment:AR; Room Air, restricted intake | Tissue:Lung	Treatment:AR; Room Air, restricted intake | Tissue:Lung	Treatment:AR; Room Air, restricted intake | Tissue:Lung	Treatment:AR; Room Air, restricted intake | Tissue:Plasma	Treatment:AR; Room Air, restricted intake | Tissue:Plasma	Treatment:AR; Room Air, restricted intake | Tissue:Plasma	Treatment:AR; Room Air, restricted intake | Tissue:Plasma	Treatment:AR; Room Air, restricted intake | Tissue:Plasma	Treatment:AR; Room Air, restricted intake | Tissue:Plasma	Treatment:AR; Room Air, restricted intake | Tissue:Plasma	Treatment:AR; Room Air, restricted intake | Tissue:Plasma	Treatment:ON; 75% oxygen, normal litter | Tissue:Lung	Treatment:ON; 75% oxygen, normal litter | Tissue:Lung	Treatment:ON; 75% oxygen, normal litter | Tissue:Lung	Treatment:ON; 75% oxygen, normal litter | Tissue:Lung	Treatment:ON; 75% oxygen, normal litter | Tissue:Lung	Treatment:ON; 75% oxygen, normal litter | Tissue:Lung	Treatment:ON; 75% oxygen, normal litter | Tissue:Lung	Treatment:ON; 75% oxygen, normal litter | Tissue:Lung	Treatment:ON; 75% oxygen, normal litter | Tissue:Plasma	Treatment:ON; 75% oxygen, normal litter | Tissue:Plasma	Treatment:ON; 75% oxygen, normal litter | Tissue:Plasma	Treatment:ON; 75% oxygen, normal litter | Tissue:Plasma	Treatment:ON; 75% oxygen, normal litter | Tissue:Plasma	Treatment:ON; 75% oxygen, normal litter | Tissue:Plasma	Treatment:ON; 75% oxygen, normal litter | Tissue:Plasma	Treatment:ON; 75% oxygen, normal litter | Tissue:Plasma	Treatment:OR; 75% oxygen, restricted intake | Tissue:Lung	Treatment:OR; 75% oxygen, restricted intake | Tissue:Lung	Treatment:OR; 75% oxygen, restricted intake | Tissue:Lung	Treatment:OR; 75% oxygen, restricted intake | Tissue:Lung	Treatment:OR; 75% oxygen, restricted intake | Tissue:Lung	Treatment:OR; 75% oxygen, restricted intake | Tissue:Lung	Treatment:OR; 75% oxygen, restricted intake | Tissue:Lung	Treatment:OR; 75% oxygen, restricted intake | Tissue:Lung	Treatment:OR; 75% oxygen, restricted intake | Tissue:Plasma	Treatment:OR; 75% oxygen, restricted intake | Tissue:Plasma	Treatment:OR; 75% oxygen, restricted intake | Tissue:Plasma	Treatment:OR; 75% oxygen, restricted intake | Tissue:Plasma	Treatment:OR; 75% oxygen, restricted intake | Tissue:Plasma	Treatment:OR; 75% oxygen, restricted intake | Tissue:Plasma	Treatment:OR; 75% oxygen, restricted intake | Tissue:Plasma	Treatment:OR; 75% oxygen, restricted intake | Tissue:Plasma
11_12_15-THET																																
11_12-DiHETrE					2.5400	5.9200	6.7100	7.3800					16.8000	12.5000	15.6000	4.9000					11.6000	13.9000	7.8200	13.1000					14	16.7000	23.8000	17
11(12)-EpETE																																
11(12)-EpETrE					0.8770	0.8440	1.4200	1.2000					0.9400	0.9490	1.3000	1.3300					1.3600	2.6800	1.0600	2.0600					1.2200	1.0200	1.7100	1.7700
11-HETE					5.9400	6.0200	11	4.2700					7	4.5000	8.2500	7.8100					6.5300	18.9000	16.4000	7.2900					19.3000	8.5900	13.7000	10.4000
12_13-DiHODE					12.1000	7.9700	15.4000	14					14.4000	12.5000	24.2000	13.6000					7.4100	17.3000	13.6000	8.8600					6.8000	10.4000	14	20.6000
12_13-DiHOME					126	74.2000	180	161					191	169	336	189					94.2000	209	168	87.1000					115	143	173	267
12(13)-Ep-9-KODE					20.4000	21.9000	43	5.3300					74.6000	28.6000	66.3000	73.4000					10.3000	73	87.5000	41					44.7000	23.2000	41.6000	214
12(13)-EpODE					0.4760	0.3930	2.2700	2.1600					0.7910	1.8700	3.6100	0.4890					1.4900	0.8750	1.8400	14.5000					0.8210	0.4260	0.4470	1.7900
12(13)-EpOME					7.7300	5.9900	31.2000	26.4000					17.1000	25.1000	63.2000	8.0200					25.1000	15.4000	33.7000	219					12.2000	9.2400	9.8500	29.9000
12-HEPE					19.7000	20.8000	42.6000	5.1300					20.1000	8.5200	36.2000	26.5000					9.5400	82.6000	67.8000	17.9000					59	23.1000	43.8000	40.4000
12-HETE					406	435	934	107					441	202	633	447					197	1460	1530	345					1050	349	766	776
12-HpETE screen																																
13-HODE					697	695	1420	383					1520	650	2700	1650					408	3060	3600	820					1120	765	2160	2870
13-HOTE					53.7000	78.4000	131	22.9000					120	46	228	143					24.1000	241	288	56.3000					87.3000	46.2000	146	189
13-HpODE screen																																
13-KODE					37.4000	30	60.3000	16.3000					77.6000	26.4000	98.5000	79.8000					15.8000	106	102	45					42.7000	27.7000	75.1000	210
14_15-DiHETE					2.6700	6.3300	6.1500	5.6100					8.0500	7.5000	9.2500	5.9100					5.7800	9.3500	5.7000	5.7300					9.1800	8.6000	15.9000	9.6600
14_15-DiHETrE					4.6600	8.3900	9.4400	11.7000					27.1000	17.3000	23.1000	7.6400					11.4000	14.9000	8.3000	10.1000					15.6000	18.4000	31.1000	20.6000
14(15)-EpETE																																
14(15)-EpETrE					0.6050	0.7260	0.8880	0.7030					1.1000	0.6910	0.8550	0.5880					1.4900	1.2400	0.8160	2.1700					0.8250	0.7570	0.8210	1.3100
14-HDoHE					106	208	271	26.1000					174	92.9000	330	186					56.5000	591	871	132					491	115	380	380
15_16-DiHODE					60.1000	44.1000	60.4000	53.5000					92.6000	68.6000	111	91					36.4000	114	61.3000	32.6000					71.6000	99	117	94.5000
15(16)-EpODE					29.2000	16.8000	59.2000	46.6000					53.2000	61.2000	111	57.5000					47.7000	86.9000	77	83					75.7000	54.2000	62.9000	97.2000
15-deoxy PGJ2																																
15-HEPE					9.8800	15	23.7000	3.6400					15	6.7100	23.8000	16.6000					3.1900	46.1000	51.7000	8.7800					31	10.8000	27.8000	23.7000
15-HETE					29.8000	46.9000	75.8000	11.5000					42.1000	25.2000	83.9000	43.3000					18.8000	132	168	30					84.6000	31.6000	82.6000	82.6000
15-HETrE					11	17.7000	27.4000	4.7500					15.4000	8.5700	34.3000	22.8000					5.3100	54.6000	62.1000	12.4000					36.3000	12.9000	32.5000	29.5000
15-HpETE screen																																
15-KETE					0.6850	4.2700	2.5400	1.5000					3.9800	1.2200	2.2900	6.2900					2.9500	6.1900	5.2800	4.5900					6.1000	2.8300	7.0500	13.6000
16(17)-EpDPE																																
17_18-DiHETE					30.6000	23.1000	34.7000	35.9000					29.1000	27.2000	40.5000	36.1000					26.2000	60.9000	37.1000	23.7000					37.2000	57.6000	85.2000	63
17(18)-EpETE					0.7250	0.3590	1.5700	1.6900					0.9590	0.9690	1.2600	0.9370					0.9700	1.7900	1.4000	2.6200					0.9920	0.9470	0.8490	1.1900
17-HDoHE					135	249	342	36.2000					164	94.4000	434	158					53.4000	570	695	98.3000					488	107	291	279
19_20-DiHDoPA					2.9200	2.7500	2.7200	2.6800					3.5200	5.7400	3.5300	2.7600					2.7500	9.2200	2.8300	2.9200					4.2400	8.2800	8.0500	8.7500
19(20)-EpDPE					1.8800	1.7800	3.2900	3.6000					2.4500	2.7600	3.1700	3.3200					3.6900	3.5500	2.4300	5					4.0500	3.1600	3	4.7700
20-carboxy-LTB4																																
20-HETE					3.7900	2.1300	0.5520	5.7600					4.1900	1	2.8200	10.5000					6.2300	7.8200	5.8500	13.7000					13.8000	11.4000	10.2000	7.0500
20-hydroxy-LTB4																																
4-HDoHE					3.1400	2.7300	4.6500	3.2200					3.1200	2.4500	4.6800	3.1900					6.2200	9.4100	6.8700	3.7000					5.7900	4.2000	5.1600	6.4800
5_15-DiHETE					0.3020	0.3330	0.5230	0.3300					0.4010	0.2890	0.4340	0.3070					0.2740	1.2500	1.1200	0.1840					0.3020	0.5730	0.3670	0.4850
5_6-DiHETrE					0.1940	0.3910	0.4240	0.3830					0.9860	0.3940	0.5850	0.3080					0.7210	0.7780	0.5610	0.6580					1.4400	1.4900	1.8900	1.1300
5-HEPE					1.1500	1.0400	1.3800	1.4200					1.1900	0.6500	2.0700	1.2900					1.6100	2.7700	2.0400	1.8200					2.3700	2.6600	2.6900	2.1100
5-HETE					7.1400	5.1800	10.5000	6.2700					6.8700	6.4900	9.3700	9.7900					11.8000	23	16.2000	10.5000					22.1000	12	15.1000	17.2000
5-HpETE screen																																
5-KETE					0.7090	0.6220	0.6850	0.3880					1.0100	0.5330	0.9990	1.6300					0.9090	1.6000	1.7700	1.0900					2.0600	1.2200	1.6600	2.0200
6-keto PGF1a					0.3680	0.3310	0.9730	0.3820					0.1740	0.6350	0.6640	0.4920					0.5690	1.0400	0.4950	1.1500					2.9000	0.8340	0.9520	1.4700
6-trans-LTB4					3.9800	4.0300	8	0.7140					10.1000	2.9700	8.9300	10.5000					1.8300	14.1000	28.9000	4.0400					20.2000	4.3200	13.4000	16.3000
8_15-DiHETE					0.6160	0.7450	0.8410	0.2940					1.0700	0.8410	2.1600	1.9100					0.6960	4.9200	8.2300	1.2900					2.4100	0.9020	4.0200	3.8400
8_9-DiHETrE					0.9340	1.4300	1.2100	2.0100					4.3200	2.8600	3.3600	1.6400					2.6500	3.9200	2.0400	2.5800					4.2100	4.8400	7.1500	4.5600
8(9)-EpETrE																																
8-HETE					6.7100	9.9400	15.1000	3.6400					8.7500	5.6900	13.1000	12					5.9100	25.5000	32.3000	8.3200					20.7000	9.4800	19.9000	17.2000
9_10-13-TriHOME					34.4000	19.7000	75.6000	11.4000					37.5000	15.6000	76.2000	58					12.2000	93.3000	97	21.2000					36.2000	16.5000	46	89.2000
9_10-DiHODE					4.4300	3.0200	5.8300	5.8200					5.5000	5.1300	9.2300	5.6900					3.2600	6.1600	4.3100	5.1200					3.2200	3.9200	5.0700	8.0600
9_10-DiHOME					300	224	380	378					554	406	779	461					223	528	367	297					317	364	485	662
9(10)-EpODE					2.2500	0.9870	3.7500	1.9100					3.0100	2.9700	7.5600	3.0100					2.4300	5.1000	4.4200	6.6500					3.7700	2.0500	3.3200	6.4300
9(10)-EpOME					2.4900	2.9200	6.8400	5.5800					5.6800	5.1100	16.3000	3.9300					5.9700	6.6200	8.8800	24.6000					4.8400	3.7200	4.2500	10
9_12_13-TriHOME					30.1000	17.8000	69.8000	10.2000					30.9000	12.7000	66.9000	60.9000					10.9000	113	91.8000	14.5000					35.4000	13.8000	48.5000	81.3000
9-HEPE					0.4990	0.5580	0.6920	0.3680					0.5000	0.4040	0.6620	0.5620					0.4020	1.5200	1.3900	0.6820					0.9790	0.8300	1.1900	0.7750
9-HETE					2.3200	3.5000	6.1500	1.7400					3.2600	1.9000	5.8300	3.6400					3.0800	9.7200	8.6000	2.9300					7.4600	3.5800	6.3200	6.1400
9-HODE					55.3000	51	96.2000	60.6000					90.8000	54.8000	166	73.9000					81.7000	220	155	111					105	118	174	222
9-HOTE					5.6800	4.7000	8.6900	5.3100					9.4700	5.9900	16.3000	8.2400					9.9300	25.6000	20.4000	13.9000					10.2000	15.1000	21.4000	29.2000
9-HpODE screen																																
9-KODE					17.1000	14.1000	28.3000	5.2900					21	13.5000	42.4000	18.9000					16.9000	39.2000	46.3000	23.8000					25.2000	21.2000	30.6000	53.1000
Hepoxilin A3																																
Lipoxin A4					1.0700	2.0700	1.9600	1.2100					0.9410	0.5680	1.7500	0.7460					1.7300	4.3300	2.1400	1.8700					1.5900	1.4900	2.5800	2.1500
LTB4																																
LTB5																																
LTE4																																
PGD2					7.2000	1.4500	7.0500	1.4500					2.8700	1.7500	1.8700	0.8660					1.1200	12.8000	2.8100	4.5300					7.8100	3.6400	2.8900	4.1300
PGE1																																
PGE2					10.1000	2.9800	11.8000	2.3300					5.2900	1.6800	2.3200	1.9400					1.7400	16.9000	1.9400	7.2700					8.6400	5.9700	3.4800	2.9900
PGE3																																
PGF2a					4.1400	0.7750	3.6000	0.6710					2.8200	0.1340	0.6780	0.5720					0.3740	2.6100	0.1400	0.4240					2.5600	0.5180	0.5070	0.8190
PGF3																																
PGJ2/ d 12-PGJ2					0.8710	0.1420	0.8560	0.2140					0.5230	0.3720	0.0940	0.1960					0.1920	1.1600	0.4090	0.4580					0.9670	0.2650	0.6760	0.2510
Resolvin D1																																
Resolvin E1																																
TXB2					5.1700	4.2300	11	1.6600					3.7000	1.8000	3.2900	3.0900					5.6400	24.1000	2.5300	13.2000					35.6000	18.3000	8.5600	5.1100
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name	moverz_quant	ri	ri_type	pubchem_id	inchi_key	kegg_id	other_id	other_id_type
11,12,15-THET				11954043				UCDavis_Newman_ID
11,12-DiHETrE				5283146				UCDavis_Newman_ID
11(12)-EpETE				16061087				UCDavis_Newman_ID
11(12)-EpETrE				5283204				UCDavis_Newman_ID
11-HETE				14123410				UCDavis_Newman_ID
12,13-DiHODE				16061067				UCDavis_Newman_ID
12,13-DiHOME				10236635				UCDavis_Newman_ID
12(13)-Ep-9-KODE				5283007				UCDavis_Newman_ID
12(13)-EpODE				16061061				UCDavis_Newman_ID
12(13)-EpOME				5356421				UCDavis_Newman_ID
12-HEPE				10041593				UCDavis_Newman_ID
12-HETE				13786989				UCDavis_Newman_ID
12-HpETE screen				5280892				UCDavis_Newman_ID
13-HODE				5282947				UCDavis_Newman_ID
13-HOTE				10469728				UCDavis_Newman_ID
13-HpODE screen				5280720				UCDavis_Newman_ID
13-KODE				6446027				UCDavis_Newman_ID
14,15-DiHETE				16061119				UCDavis_Newman_ID
14,15-DiHETrE				5283147				UCDavis_Newman_ID
14(15)-EpETE				16061088				UCDavis_Newman_ID
14(15)-EpETrE				5283205				UCDavis_Newman_ID
14-HDoHE				11566378				UCDavis_Newman_ID
15,16-DiHODE				16061068				UCDavis_Newman_ID
15(16)-EpODE				16061056				UCDavis_Newman_ID
15-deoxy PGJ2				5311211				UCDavis_Newman_ID
15-HEPE				16061131				UCDavis_Newman_ID
15-HETE				9966861				UCDavis_Newman_ID
15-HETrE				44322431				UCDavis_Newman_ID
15-HpETE screen				5280893				UCDavis_Newman_ID
15-KETE				5280701				UCDavis_Newman_ID
16(17)-EpDPE				14392758				UCDavis_Newman_ID
17,18-DiHETE				16061120				UCDavis_Newman_ID
17(18)-EpETE				16061089				UCDavis_Newman_ID
17-HDoHE				6439179				UCDavis_Newman_ID
19,20-DiHDoPA				16061148				UCDavis_Newman_ID
19(20)-EpDPE				11631565				UCDavis_Newman_ID
20-carboxy-LTB4				5280877				UCDavis_Newman_ID
20-HETE				123803				UCDavis_Newman_ID
20-hydroxy-LTB4				5280877				UCDavis_Newman_ID
4-HDoHE				14429109				UCDavis_Newman_ID
5,15-DiHETE				59878863				UCDavis_Newman_ID
5,6-DiHETrE				5283142				UCDavis_Newman_ID
5-HEPE				6439678				UCDavis_Newman_ID
5-HETE				9862886				UCDavis_Newman_ID
5-HpETE screen				5283171				UCDavis_Newman_ID
5-KETE				5283159				UCDavis_Newman_ID
6-keto PGF1a				5280888				UCDavis_Newman_ID
6-trans-LTB4				5283128				UCDavis_Newman_ID
8,15-DiHETE				53480358				UCDavis_Newman_ID
8,9-DiHETrE				5283144				UCDavis_Newman_ID
8(9)-EpETrE				5353364				UCDavis_Newman_ID
8-HETE				11976122				UCDavis_Newman_ID
9,10-13-TriHOME				5282965				UCDavis_Newman_ID
9,10-DiHODE				16061066				UCDavis_Newman_ID
9,10-DiHOME				9966640				UCDavis_Newman_ID
9(10)-EpODE				16061060				UCDavis_Newman_ID
9(10)-EpOME				6246154				UCDavis_Newman_ID
9,12,13-TriHOME				9858729				UCDavis_Newman_ID
9-HEPE				16061129				UCDavis_Newman_ID
9-HETE				14123398				UCDavis_Newman_ID
9-HODE				5282944				UCDavis_Newman_ID
9-HOTE				53480359				UCDavis_Newman_ID
9-HpODE screen				6439847				UCDavis_Newman_ID
9-KODE				9839084				UCDavis_Newman_ID
Hepoxilin A3				5460414				UCDavis_Newman_ID
Lipoxin A4				5280914				UCDavis_Newman_ID
LTB4				5280492				UCDavis_Newman_ID
LTB5				5283125				UCDavis_Newman_ID
LTE4				5280879				UCDavis_Newman_ID
PGD2				448457				UCDavis_Newman_ID
PGE1				5280723				UCDavis_Newman_ID
PGE2				5280360				UCDavis_Newman_ID
PGE3				5280937				UCDavis_Newman_ID
PGF2a				5280363				UCDavis_Newman_ID
PGF3				5280940				UCDavis_Newman_ID
PGJ2/ d 12-PGJ2				5280885				UCDavis_Newman_ID
Resolvin D1				16061135				UCDavis_Newman_ID
Resolvin E1				44251266				UCDavis_Newman_ID
TXB2				5283137				UCDavis_Newman_ID
METABOLITES_END
#END
